Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening

Journal of Medical Virology

Volumn 87, Issue 3, 2015, Pages 508-515

  Burroni, Elena ^a   Bonanni, Paolo ^b   Sani, Cristina ^a   Lastrucci, Vieri ^b   Carozzi, Francesca ^a   Iossa, Anna ^c   Andersson, Karin Louise ^c   Brandigi, Livia ^c   Pierro, Carmelina Di ^c   Confortini, Massimo ^c   Levi, Miriam ^c   Boccalini, Sara ^c   Indiani, Laura ^c   Sala, Antonino ^c   Tanini, Tommaso ^c   Bechini, Angela ^c   Azzari, Chiara ^c  

^a ISPO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c NONE

Author keywords

Cervical samples; HPV genotyping; Human papillomavirus; Urine

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; UTERINE CERVIX; UTERINE CERVIX CANCER; VACCINATION; VIRUS DETECTION; WART VIRUS; ADULT; CLASSIFICATION; COMPARATIVE STUDY; EPIDEMIOLOGY; EVALUATION STUDY; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; ITALY; MASS SCREENING; MOLECULAR DIAGNOSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); URINE; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADULT; CERVIX UTERI; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; ITALY; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINE; UTERINE CERVICAL NEOPLASMS;

EID: 84921342014     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24085     Document Type: Article

References (38)

1. Alameda F, Bellosillo B, Fusté P, Musset M, Mariñoso ML, Mancebo G, Lopez-Yarto MT, Carreras R, Serrano S. 2007. Human papillomavirus detection in urine samples: An alternative screening method. J Low Genit Tract Dis 11:5-7.
2. Bauer HM, Greer CE, Manos MM. 1992. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington CS, O'D McGee J, editors. Diagnostic molecular pathology: A practical approach. Oxford: Oxford University Press, pp 131-152.
3. Bissett SL, Howell-Jones R, Swift C, De Silva N, Biscornet L, Parry JV, Saunders NA, Nathan M, Soldan K, Szarewski A, Cuzick J, Beddows S. 2011. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol 83:1744-1751. Erratum in: 2011. J Med Virol. 83:2237. .
4. Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, Panatto D, Gasparini R, Boccalini S. 2011. An overview on the implementation of HPV vaccination in Europe. Human Vaccines 7:128-135.
5. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part B: Biological agents. Lancet Oncol 10:321-322.
6. Brinkman JA, Jones WE, Gaffga AM, Sanders JA, Chaturvedi AK, Slavinsky III J, Clayton JL, Dumestre J, Hagensee ME. 2002. Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol 40:3155-3161.
7. Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Sings HL, James M, Hesley TM, Barr E. 2009. The impact of quadrivalent human papillomavirus (HPV: Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvacine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis 199:926-935.
8. Chernesky MA, Jang D, Sellors J, Luinstra K, Chong S, Castriciano S, Mahony JB. 1997. Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women. Mol Cell Probes 11:243-249.
9. Crotchfelt KA, Pare B, Gaydos C, Quinn TC. 1998. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 36:391-394.
10. Cuschieri K, Nandwani R, McGough P, Cook F, Hogg L, Robertson C, Cubie H. 2011. Urine testing as a surveillance tool to monitor the impact of HPV immunization programs. J Med Virol 83:1983-1987.
11. Daponte A, Pournaras S, Mademtzis I, Hadjichristodoulou C, Kostopoulou E, Maniatis AN, Messinis IE. 2006. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J Clin Virol 36:189-193.
12. Das BC, Gopalkrishna V, Sharma JK, Roy M, Luthra UK. 1992. Human papillomavirus DNA in urine of women with preneoplastic and neoplastic cervical lesions. Lancet 340:1417-1418.
13. D'Hauwers K, Depuydt C, Bogers JP, Stalpaert M, Vereecken A, Wyndaele JJ, Tjalma W. 2007. Urine versus brushed samples in human papillomavirus screening: Study in both genders. Asian J Androl 9:705-710.
14. Enerly E, Olofsson C, Nygård M. 2013. Monitoring human papillomavirus prevalence in urine samples: A review. Clin Epidemiol 5:67-79.
15. 2 conization for high-grade cervical intraepithelial neoplasia. Gynecol Oncol 109:59-64.
16. Feng Q, Hawes SE, Stern JE, Dem A Sow, Dembele B, Toure P, Sova P, Laird PW, Kiviat NB. 2007. Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia. Cancer Epidemiol Biomarkers Prev 16:1178-1184.
17. Forslund O, Hansson BG, Rymark P, Bjerre B. 1993. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol 31:1975-1979.
18. Gupta A, Arora R, Gupta S, Prusty BK, Kailash U, Batra S, Das BC. 2006. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens. J Clin Virol 37:190-194.
19. Herrero R. 2009. Human papillomavirus (HPV) vaccines: Limited cross-protection against additional HPV types. J Infect Dis 199:919-922.
20. Jacobson DL, Womack SD, Peralta L, Zenilman JM, Feroli K, Maehr J, Daniel RW, Shah KV. 2000. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr Infect Dis J 19:722-728.
21. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin 61:69-90. Erratum in: CA Cancer J Clin 61:134 .
22. Jenkins D. 2008. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol Oncol 110:S18-S25.
23. Jong E, Mulder JW, van Gorp EC, Wagenaar JK, Derksen J, Westerga J, Tol A, Smits PH. 2008. The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear samples of HIV-infected women. J Clin Virol 41:111-115.
24. Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, Bernstein DI. 2012. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics 130:e249-e256.
25. Khan G, Kangro HO, Coats PJ, Heath RB. 1991. Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. J Clin Pathol 44:360-365.
26. Melchers WJ, Schift R, Stolz E, Lindeman J, Quint WG. 1989. Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J Clin Microbiol 27:1711-1714.
27. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. 2003. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
28. Payan C, Ducancelle A, Aboubaker MH, Caer J, Tapia M, Chauvin A, Peyronnet D, Le Hen E, Arab Z, Legrand MC, Tran A, Postec E, Tourmen F, Avenel M, Malbois C, De Brux MA, Descamps P, Lunel F. 2007. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. J Clin Microbiol 45:897-901.
29. Rymark P, Forslund O, Hansson BG, Lindholm K. 1993. Genital HPV infection not a local but a regional infection: Experience from a female teenage group. Genitourin Med 69:18-22.
30. Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V. 2009. Urine HPV-DNA detection for cervical cancer screening: Prospects and prejudices. J Obstet Gynaecol 29:583-589. Review .
31. Smits PH, Bakker R, Jong E, Mulder JW, Meenhorst PL, Kleter B, van Doorn LJ, Quint WG. 2005. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J Clin Microbiol 43:5936-5939.
32. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr, Young N. Forum Group Members. 2002. Bethesda 2001 Workshop: The 2001 Bethesda System: Terminology for reporting results of cervical caytology. JAMA 287:2114-2119.
33. Song ES, Lee HJ, Hwang TS. 2007. Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions. J Korean Med Sci 22:99-104.
34. Stanczuk GA, Kay P, Allan B, Chirara M, Tswana SA, Bergstrom S, Sibanda EN, Williamson AL. 2003. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer. J Med Virol 71:110-114.
35. Strauss S, Jordens JZ, McBride D, Sonnex C, Edwards S, Desselberger U, Watt P, Gray JJ. 1999. Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes. Eur J Epidemiol 15:537-543.
36. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. 2011. Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Prev Med 53:S12-S21.
37. van der Hel OL, van der Luijt RB, Bueno de Mesquita, van Noord HB, Slothouber PA, Roest B, van der Schouw M, Grobbee YT, Pearson DE, Peeters PL. 2002. Quality and quantity of DNA isolated from frozen urine in population-based research. Anal Biochem 304:206-211.
38. Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, Van Damme P. 2012. Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis 31:627-640. Review .